NO157244C - Fremgangsmaate til fremstilling av en legemiddelform paa basis av granulat med forbedret magetaalbarhet. - Google Patents

Fremgangsmaate til fremstilling av en legemiddelform paa basis av granulat med forbedret magetaalbarhet.

Info

Publication number
NO157244C
NO157244C NO822399A NO822399A NO157244C NO 157244 C NO157244 C NO 157244C NO 822399 A NO822399 A NO 822399A NO 822399 A NO822399 A NO 822399A NO 157244 C NO157244 C NO 157244C
Authority
NO
Norway
Prior art keywords
preparation
stomachability
granulate
procedure
improved
Prior art date
Application number
NO822399A
Other languages
English (en)
Norwegian (no)
Other versions
NO157244B (no
NO822399L (no
Inventor
Klaus Gleixner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6136567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO157244(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO822399L publication Critical patent/NO822399L/no
Publication of NO157244B publication Critical patent/NO157244B/no
Publication of NO157244C publication Critical patent/NO157244C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Photolithography (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Fishing Rods (AREA)
NO822399A 1981-07-10 1982-07-09 Fremgangsmaate til fremstilling av en legemiddelform paa basis av granulat med forbedret magetaalbarhet. NO157244C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813127237 DE3127237A1 (de) 1981-07-10 1981-07-10 Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO822399L NO822399L (no) 1983-01-11
NO157244B NO157244B (no) 1987-11-09
NO157244C true NO157244C (no) 1988-02-24

Family

ID=6136567

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822399A NO157244C (no) 1981-07-10 1982-07-09 Fremgangsmaate til fremstilling av en legemiddelform paa basis av granulat med forbedret magetaalbarhet.

Country Status (17)

Country Link
US (1) US4542011A (fr)
EP (1) EP0069958B2 (fr)
JP (1) JPS5818318A (fr)
KR (1) KR880000971B1 (fr)
AT (1) ATE18851T1 (fr)
AU (1) AU553925B2 (fr)
CA (1) CA1178204A (fr)
DD (1) DD202502A5 (fr)
DE (2) DE3127237A1 (fr)
DK (1) DK166758B1 (fr)
FI (1) FI81259C (fr)
HU (1) HU187774B (fr)
IE (1) IE53581B1 (fr)
IL (1) IL66282A (fr)
NO (1) NO157244C (fr)
PT (1) PT75217B (fr)
ZA (1) ZA824901B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4874605A (en) * 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2013045352A1 (fr) 2011-09-30 2013-04-04 Basf Se Procédé de fabrication d'agents de pelliculage solides contenant des pigments, sous forme de granulés à base d'agents filmogènes gastrorésistants pour l'enrobage de formes galéniques

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064230A (en) * 1966-04-25 1977-12-20 Schmid Laboratories, Inc. Polyenic macrolide compositions
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
BE725125A (fr) * 1967-12-16 1969-06-09
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
IL45337A (en) * 1973-08-10 1977-04-29 Saarstickstoff Fatol Gmbh Therapeutical composition containing an isonicotinic acid hydrazide thioisonicotinic acid amide sulfones and/or sulfonamides for the treatment of mycobacterioses
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
AR215459A1 (es) * 1976-04-02 1979-10-15 Brewer J Metodo para producir un agente terapeutico capaz de proporcionar una marca en un animal no humano para indicar la administracion del agente al animal y para proporcionar tambien un repositorio del agente a ser libeberado durante un espacio de tiempo
US4096252A (en) * 1976-06-10 1978-06-20 J. Uriach & Cia S.A. 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
EP0005015B1 (fr) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Utilisation d'un dérivé de xanthine dans la fabrication d'un médicament
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
CH647676A5 (fr) * 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
JPS5611687A (en) * 1980-06-02 1981-02-05 Fujitsu Ltd Semiconductor memory unit

Also Published As

Publication number Publication date
KR880000971B1 (ko) 1988-06-07
ZA824901B (en) 1983-04-27
IE53581B1 (en) 1988-12-21
IE821661L (en) 1983-01-10
US4542011A (en) 1985-09-17
FI81259C (fi) 1990-10-10
DK166758B1 (da) 1993-07-12
EP0069958A3 (en) 1983-06-29
CA1178204A (fr) 1984-11-20
JPH0419969B2 (fr) 1992-03-31
DE3270241D1 (en) 1986-05-07
JPS5818318A (ja) 1983-02-02
ATE18851T1 (de) 1986-04-15
IL66282A0 (en) 1982-11-30
DD202502A5 (de) 1983-09-21
FI822441L (fi) 1983-01-11
KR840000238A (ko) 1984-02-18
NO157244B (no) 1987-11-09
DK310582A (da) 1983-01-11
PT75217A (de) 1982-08-01
NO822399L (no) 1983-01-11
AU8578082A (en) 1983-01-13
EP0069958B2 (fr) 1991-03-27
DE3127237A1 (de) 1983-01-20
FI81259B (fi) 1990-06-29
EP0069958B1 (fr) 1986-04-02
AU553925B2 (en) 1986-07-31
EP0069958A2 (fr) 1983-01-19
HU187774B (en) 1986-02-28
FI822441A0 (fi) 1982-07-08
IL66282A (en) 1987-01-30
PT75217B (de) 1985-01-07

Similar Documents

Publication Publication Date Title
NO157244C (no) Fremgangsmaate til fremstilling av en legemiddelform paa basis av granulat med forbedret magetaalbarhet.
SE8603247D0 (sv) Farmaceutiskt granulat
DE3067536D1 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
EP0092190A3 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
SE8204581D0 (sv) New pharmaceutical sustained-release compositions
ATE33097T1 (de) Zusammensetzung zum ueberziehen von nahrungsund arzneimitteln und derart ueberzogene granulate.
GB2140412B (en) Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof
FI883068A0 (fi) Menetelmä kovan granulimateriaalin valmistamiseksi leijukerrostuhkasta
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
DE3272602D1 (en) Solid galenic form for oral administration and process for its preparation
AT382076B (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
JPS5770888A (en) Benzothiazine derivative, its preparation and medicinal composition
IL65443A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
DE3160959D1 (en) Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical composition, containing at least one of these compounds
GB2033902B (en) 1,6-naphthyridine derivatives process for the production thereof and pharmaceutical composition containing such derivatives
DK357182A (da) Forbindelse med anti-ulcerogen virkning, fremgangsmaade til dens fremstilling og farmaceutiske midler deraf
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
JPS52130905A (en) Medicinal composition
DE3262587D1 (en) Leukotriene analogues, their preparation and use in pharmaceutical compositions
GB2015525B (en) Naphthopytan derivatives the salts thereof processes for their preparation and pharmaceutical compositions containing them
JPS5277372A (en) Preventing method for scattering of dust or powder carried on conveyor
JPS5573608A (en) Stable diagnosing drug for radioactive technetium labeling
KR880012206A (ko) 구강질환 치료 조성물